Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adeera Levin

Showing results (411-420 of 628) with videos related to

Pageof 63
Sort By:
BMJ Open|July 16, 2025
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic reviewAnastasia Hughes, Angela Ju, Rosanna Cazzolli, et al.
Pediatrics|June 5, 2003
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratificationRonald J Hogg, Susan Furth, Kevin V Lemley, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE TrialDavid M Charytan, Jie Yu, Meg J Jardine, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2015
Past Decline Versus Current eGFR and Subsequent ESRD RiskCsaba P Kovesdy, Josef Coresh, Shoshana H Ballew, et al.
Diabetes, Obesity & Metabolism|January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trialAmanda Siriwardana, Luke Buizen, Min Jun, et al.
International Journal of Epidemiology|December 18, 2012
Cohort profile: the chronic kidney disease prognosis consortiumKunihiro Matsushita, Shoshana H Ballew, Brad C Astor, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trialSimon D Roger, Lawrence P McMahon, Anthony Clarkson, et al.
Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 10, 2016
Evaluation of a 12-Month Pilot of Long-Term and Temporary Assisted Peritoneal DialysisMicheli U Bevilacqua, Linda Turnbull, Sushila Saunders, et al.
Journal of the American College of Cardiology|May 4, 2004
The profile of cardiac patients with renal artery stenosisChristopher E Buller, Jorge G Nogareda, Krishnan Ramanathan, et al.
Pageof 63

Showing results (411-420 of 628) with videos related to

Sort By:
Pageof 63
BMJ Open|July 16, 2025
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic reviewAnastasia Hughes, Angela Ju, Rosanna Cazzolli, et al.
Pediatrics|June 5, 2003
National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratificationRonald J Hogg, Susan Furth, Kevin V Lemley, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2022
Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE TrialDavid M Charytan, Jie Yu, Meg J Jardine, et al.
Journal of the American Society of Nephrology : JASN|December 15, 2015
Past Decline Versus Current eGFR and Subsequent ESRD RiskCsaba P Kovesdy, Josef Coresh, Shoshana H Ballew, et al.
Diabetes, Obesity & Metabolism|January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trialAmanda Siriwardana, Luke Buizen, Min Jun, et al.
International Journal of Epidemiology|December 18, 2012
Cohort profile: the chronic kidney disease prognosis consortiumKunihiro Matsushita, Shoshana H Ballew, Brad C Astor, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trialSimon D Roger, Lawrence P McMahon, Anthony Clarkson, et al.
Stroke|April 20, 2021
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-AnalysisZien Zhou, Meg J Jardine, Qiang Li, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 10, 2016
Evaluation of a 12-Month Pilot of Long-Term and Temporary Assisted Peritoneal DialysisMicheli U Bevilacqua, Linda Turnbull, Sushila Saunders, et al.
Journal of the American College of Cardiology|May 4, 2004
The profile of cardiac patients with renal artery stenosisChristopher E Buller, Jorge G Nogareda, Krishnan Ramanathan, et al.
Pageof 63